Pharmacy

Dec 24 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #big #pharma #etf

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Dec 21 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #analytics

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Dec 8 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #lupin #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 22 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #industry #news

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 16 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #api #pharma

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Nov 9 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharmaceutical #industry #data

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Aug 25 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #uman #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 14 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #emcure #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 7 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #top #drug #manufacturers

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Aug 7 2017

Addison news, events, sports, business and photos #newspaper, #chicago, #suburbs, #tribune, #suntimes, #local, #national, #sports, #bulls, #sox, #cubs, #bears, #blackhawks

# Current Weather Communities Addison Area News Legendary Kane County leader Phil Elfstrom dies Last Updated May 30, 2017 7:02 PM With conviction in 1995 death vacated, Naperville man released on bail Updated May 31, 2017 9:57 AM William Amor is a free man for the first time since his 1995 arrest on charges that he committed the arson murder of his mother-in-law. Amor found out Sunday that a childhood friend would be traveling from Indiana to DuPage County jail Tuesday afternoon to post the required 10 percent of Amor’s $100,000 bail. Constable: Mom worried about deportation backs out of …

Aug 4 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #design

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Jul 31 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #suppliers

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jul 25 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #cipla #pharma

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Jun 25 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #biotechnology #industry

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jun 16 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #usv #pharma

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Jun 13 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #the #pharmaceutical #industry

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

May 13 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #times

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

May 1 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharma #sales #job

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Apr 27 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #wuxi #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Apr 18 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #inc

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Apr 13 2017

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #novadel #pharma

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Apr 9 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #akela #pharma #inc

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Mar 30 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #akela #pharma

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Jan 25 2017

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharma #research #jobs

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 24 2016

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #market #research #companies

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Nov 11 2016

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #pharmaceutical #companies #in #houston #tx

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Nov 7 2016

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #alembic #pharma

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Oct 29 2016

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #pharmaceutical #firms

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Oct 23 2016

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune #ciba #pharmaceuticals

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Oct 4 2016

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune #generic #pharma #companies

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Sep 30 2016

German pharmaceutical firm strikes state deal for Des Plaines facility – Chicago Tribune

#pharmaceutical companies in chicago # German pharmaceutical firm strikes state deal for Des Plaines facility A German pharmaceutical manufacturer plans to build a production facility in suburban Des Plaines that would create at least 300 jobs, Illinois officials said Tuesday. The project would be one of the largest economic-development victories in Des Plaines history, said City Manager Michael Bartholomew. Vetter, based in Ravensburg, Germany, has signed an economic development agreement with the state. The news release from the Department of Commerce and Economic Opportunity did not provide details of financial incentives Illinois plans to give Vetter. A department spokeswoman was …

Sep 26 2016

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …

Sep 17 2016

Horizon Pharma to buy Lake Forest company for $510 million – Chicago Tribune

#horizon pharma # Horizon Pharma to buy Lake Forest company for $510 million Fast-growing Horizon Pharma is spending $510 million to buy Crealta Holdings, of Lake Forest, which makes the only approved medicine for chronic refractory gout, a disorder that affects about 50,000 Americans. The definitive agreement, announced Friday, is the latest move by Horizon to become a major pharmaceutical player, primarily through acquisitions. The company said last month its sales will double in the next four years, led by its orphan drug business. Orphan drugs, which treat rare diseases, often command high prices and profits. Horizon Pharma expects sales …